PF-07225570
- Generic Name
- PF-07225570
PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- Pfizer
- Registration Number
- NCT05259397
- Locations
- 🇵🇱
Szpital Specjalistyczny im. Sw. Rodziny SPZOZ, Warszawa, Poland
🇵🇱Medical Concierge Centrum Medyczne, Warszawa, Poland
🇺🇸Columbia University Medical Center - Herbert Irving Pavilion, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath